Ascendis Pharma AS (NAS:ASND)
$ 151.26 -2.17 (-1.41%) Market Cap: 8.67 Bil Enterprise Value: 9.12 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 74/100

Ascendis Pharma A/S - Special Call Transcript

Apr 19, 2020 / 10:00PM GMT
Operator

Good evening, everyone. My name is Jeff, and I'll be your conference operator today. At this time, I would like to welcome everyone to the Ascendis Pharma Top-Line Phase II PaTH Forward Data Conference Call. (Operator Instructions)

Thank you. I would now like to turn the call over to our speaker today, Mr. Scott Smith, Senior Vice President and Chief Financial Officer of Ascendis Pharma. You may begin your conference.

Scott T. Smith;S;CFO
Ascendis Pharma A;Senior VP & Member of Executive Board

/- -

Thank you, operator. Thank you, everyone, for joining our Top-Line Phase II PaTH Forward data results conference call today.

I'm Scott Smith, Chief Financial Officer of Ascendis. Joining me on today's call is Jan Mikkelsen, President and Chief Executive Officer; and Dr. Dana Pizzuti, Head of Development Operations.

Before we begin, I would like to remind you that this conference call will contain forward-looking statements that are intended to be covered under the safe harbor provided by the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot